Europe Neurovascular Devices/interventional Neurology Market Forecast 2023-2032

The Europe neurovascular devices/interventional neurology market is evaluated to grow with a CAGR of 5.01% during the forecast years of 2023 to 2032. The geriatric population's high susceptibility to neurological illnesses, like strokes and vascular disorders, as well as the advent of teleconsultation and telemedicine services, especially in underserved or rural areas, are among the top factors fueling the market growth of the region.

MARKET INSIGHTS

The Europe neurovascular devices/interventional neurology market growth evaluation covers the study of the United Kingdom, Spain, Poland, Belgium, Germany, France, Italy, and Rest of Europe. The French government has taken significant strides in addressing specific neurological conditions, such as epilepsy, Alzheimer's disease, and Parkinson's disease, through various national initiatives. These initiatives aim to advance research, diagnosis, and therapy for these disorders while also providing support to patients as well as their families.

A key endeavor is the upcoming Booster Program, including the NeuroTechnologies Program, set to be launched by Inserm in France in 2023. The government has also allocated substantial funding to drive brain research, encompassing basic neuroscience research, translational research, and clinical trials. Furthermore, the French government supports the National Multidisciplinary Consortium for 119 Certified Research Teams in Autism and Neurodevelopmental Disorders as part of its commitment to the National Autism and Neurodevelopmental Disorders Strategy. Patients with neurological conditions receive essential services, with a focus on improving functional outcomes and quality of life through funding for neurorehabilitation facilities and programs. Hence, such factors are set to propel the region's market growth during the forecast period.

COMPETITIVE INSIGHTS

Some of the main companies operating in the market are: Phenox Inc, Acandis GmbH, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 67114

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
- 2.5.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
- 2.5.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
- 3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
- 3.1.3. GERIATRIC POPULATION'S VULNERABILITY TO NEUROVASCULAR DISEASES
- 3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
3.2. KEY RESTRAINTS
- 3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
- 3.2.2. LACK OF TRAINED NEUROSURGEONS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT

5.1. EMBOLIZATION DEVICES
- 5.1.1. EMBOLIC COILS
  - 5.1.1.1. COATED DETACHABLE COILS
  - 5.1.1.2. BARE DETACHABLE COILS
- 5.1.2. COIL ASSIST STENT
- 5.1.3. CLIPPINGS
- 5.1.4. COIL ASSIST BALLOON
5.2. ACCESSORY DEVICES
- 5.2.1. MICROCATHETERS
- 5.2.2. MICRO GUIDEWIRES
5.3. REVASCULARIZATION DEVICES
- 5.3.1. CAROTID ARTERY STENTS
- 5.3.2. FLOW DIVERSION STENTS
5.4. THROMBECTOMY DEVICES
- 5.4.1. CLOT RETRIEVAL DEVICES
- 5.4.2. SUCTION AND ASPIRATION DEVICES
- 5.4.3. SNARES
5.5. EMBOLIC PROTECTION DEVICES
- 5.5.1. BALLOON OCCLUSION DEVICES
- 5.5.2. DISTAL FILTER DEVICES

6. MARKET BY APPLICATION

6.1. ANEURYSM
6.2. ISCHEMIC STROKE
6.3. STENOSIS
6.4. ARTERIOVENOUS MALFORMATION (AVM)
6.5. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. EUROPE
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
- 7.1.3. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
- 7.1.4. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
- 7.1.5. KEY PLAYERS IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
- 7.1.6. COUNTRY ANALYSIS
  - 7.1.6.1. UNITED KINGDOM
  - 7.1.6.1.1. UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.2. GERMANY
  - 7.1.6.2.1. GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.3. FRANCE
  - 7.1.6.3.1. FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.4. ITALY
  - 7.1.6.4.1. ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.5. SPAIN
  - 7.1.6.5.1. SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.6. POLAND
  - 7.1.6.6.1. POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.7. BELGIUM
  - 7.1.6.7.1. BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  - 7.1.6.8. REST OF EUROPE
  - 7.1.6.8.1. REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
- 8.2.1. ACANDIS GMBH
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCT LIST
- 8.2.2. ASAHI INTECC
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCT LIST
- 8.2.3. BALT
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCT LIST
- 8.2.4. B BRAUN MELSUNGEN AG
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCT LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. INTEGER HOLDINGS CORPORATION
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCT LIST
  - 8.2.5.3. STRENGTHS & CHALLENGES
- 8.2.6. JOHNSON & JOHNSON (CERENOVUS)
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCT LIST
  - 8.2.6.3. STRENGTHS & CHALLENGES
- 8.2.7. KANEKA CORPORATION
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCT LIST
- 8.2.8. MEDTRONIC INC
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCT LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. MEMRY CORPORATION
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCT LIST
- 8.2.10. MICROPORT SCIENTIFIC CORPORATION
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCT LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. PENUMBRA INC
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCT LIST
- 8.2.12. PHENOX INC
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCT LIST
  - 8.2.12.3. STRENGTHS & CHALLENGES
- 8.2.13. RAPID MEDICAL
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCT LIST
  - 8.2.13.3. STRENGTHS & CHALLENGES
- 8.2.14. SENSOME
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCT LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. STRYKER CORPORATION
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCT LIST
  - 8.2.15.3. STRENGTHS & CHALLENGES
- 8.2.16. TERUMO CORPORATION
  - 8.2.16.1. COMPANY OVERVIEW
  - 8.2.16.2. PRODUCT LIST
  - 8.2.16.3. STRENGTHS & CHALLENGES

Product Code: 67114

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY
TABLE 2: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
TABLE 21: KEY PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
TABLE 22: LIST OF MERGERS & ACQUISITIONS
TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 25: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022
FIGURE 7: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 8: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022
FIGURE 9: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022
FIGURE 11: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2032 (IN $ MILLION)
FIGURE 13: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2032 (IN $ MILLION)
FIGURE 16: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 17: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022
FIGURE 18: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2032 (IN $ MILLION)
FIGURE 19: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2032 (IN $ MILLION)
FIGURE 20: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 21: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022
FIGURE 22: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2032 (IN $ MILLION)
FIGURE 24: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 25: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022
FIGURE 26: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 27: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 28: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2032 (IN $ MILLION)
FIGURE 29: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 30: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022
FIGURE 31: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 32: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2032 (IN $ MILLION)
FIGURE 33: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 34: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2032 (IN $ MILLION)
FIGURE 35: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2032 (IN $ MILLION)
FIGURE 36: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2032 (IN $ MILLION)
FIGURE 37: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2032 (IN $ MILLION)
FIGURE 38: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 39: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 40: UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 42: FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 45: POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 46: BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 47: REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)